News
CVS Health , which runs the largest U.S. pharmacy benefit manager, will not add Gilead Sciences' new HIV prevention drug to ...
1don MSN
CVS Caremark ordered to pay $290M after Medicare fraud scheme exposed by former Aetna whistleblower
Whistleblower Sarah Behnke's lawsuit leads to a $290 million judgment against CVS Caremark for overcharging Medicare on ...
Chief Judge Mitchell Goldberg tripled to $285 million the damages he had ordered CVS Caremark to pay in June, citing the ...
The owner of the United States' largest pharmacy benefit manager (PBM) is declining to cover Gilead Sciences’ long-acting HIV ...
A federal judge has ordered CVS Caremark to pay nearly $290 million in damages after determining the pharmacy benefit manager overbilled Medicare for prescription drugs, according to court documents ...
Gilead Needs Insurers to Cover New HIV Prevention Shot. CVS Isn’t Paying. Executives at Gilead Sciences, the biotech behind a ...
5h
Zacks Investment Research on MSNGILD Stock Slips as CVS Health Excludes New HIV Drug Yeztugo
Shares of Gilead Sciences, Inc. (GILD) tumbled 2.2% on Aug. 21, after pharmacy benefit manager CVS Health (CVS) decided not ...
A Pennsylvania judge has ordered CVS to pay $289 million in damages as part of a long-running whistleblower case. | A ...
CVS Health (CVS) stock in focus as its pharmacy benefit manager CVS Caremark faces $289.9M in damages and penalties for ...
CVS Health is not entitled to coverage from insurers, including AIG and Chubb , against thousands of lawsuits over its role ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results